NIH-funded research R01 grant

Improving CAR T cell therapy for cancer treatment

Official title: Label-free imaging of CAR T cell metabolism

Funded at Morgridge Institute for Research, INC. · NIH-10895431 · Data updated 2026-11-12

This study is looking to make CAR T cell therapies better for cancer patients by using new technology to understand how T cells work, so we can find out which patients will benefit the most and improve the treatment for everyone.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMorgridge Institute for Research, INC.
NIH-funded
Lab location1 site (Madison, United States)
Project startAugust 1, 2023
Project endJuly 31, 2028
Funding year2024
Award (this year)$615,789
NIH project number5R01CA278051-02
Project IDNIH-10895431 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with B-cell lymphomas who are considering or undergoing CAR T cell therapy.

Less likely to help

Patients with cancers other than B-cell lymphomas or those who are not eligible for CAR T cell therapy may not benefit from this research.

What this research studies

This research aims to enhance the effectiveness of CAR T cell therapies, which are a promising treatment for certain cancers. The team will develop non-invasive technologies to analyze T cell metabolism at a single-cell level, helping to identify which patients' T cells are suitable for therapy and how to optimize their production. By focusing on improving the quality of T cells used in treatment, the research seeks to overcome current limitations that prevent long-lasting remissions in many patients. The ultimate goal is to ensure that CAR T cell therapies are more potent and effective for cancer patients.

Why it matters

Potential benefit: If successful, this research could lead to more effective CAR T cell therapies, resulting in longer-lasting remissions for cancer patients.

How similar studies have gone: Other research has shown promise in enhancing CAR T cell therapies, but this approach of using non-invasive single-cell technologies is relatively novel.

Where this research is happening

  • Morgridge Institute for Research, INC.
    Madison, United States
    Active

Researchers

  • Principal investigator: Skala, Melissa Caroline — Morgridge Institute for Research, INC.
  • Study coordinator: Skala, Melissa Caroline

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.